Analysis of the Gore REVISE Clinical Study data examined reinterventions and associated costs to maintain dialysis access in thrombosed and stenotic circuits.
May 1, 2020
Apr 6, 2020
CE Mark supported by data from the Gore ASSURED Clinical Study, demonstrating 100 percent closure success
Oct 2, 2019
Gore furthers its commitment to patient-centered cardiac innovation
Sep 26, 2019
U.S. pivotal study will determine safety and effectiveness of modular device designed to be the first completely off-the-shelf endovascular solution for aortic aneurysms involving the visceral branch vessels
Jul 18, 2019
Designation recognizes products that bring improvements to the health care industry
Jul 17, 2019
Data shows 100% successful deployment and no fractures at 30-day follow-up in European Registry
Jul 10, 2019
Data from the Gore ASSURED Clinical Study demonstrated 100 percent closure success at six months
Jun 4, 2019
The device and new delivery system combine proven conformability with enhanced placement control to optimize TEVAR outcomes in even complex aortic anatomy
May 15, 2019
Company shares findings from the Global Registry for Endovascular Aortic Treatment (GREAT), the largest industry-sponsored registry of aortic stent grafts
Nov 6, 2018